#}



Atossa Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Rok finansowy 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 0.0% inf% 32022.8% 31.3% -16.9% -99.7% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 0.0% 0.0% -6379.3% 86.4% 21.7% 35.2% -7431.9% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% -inf%
EBIT (mln) -0 -1 -3 -5 -11 -15 -13 -8 -8 -11 -17 -15 -21 -28 -31 -28
EBIT Δ r/r 0.0% 777.4% 218.1% 47.8% 112.8% 35.8% -12.9% -37.5% -4.0% 49.5% 51.0% -15.4% 40.5% 34.9% 13.3% -12.0%
EBIT (%) 0.0% 0.0% -228612.7% -1052.0% -1704.9% -2784.0% -725746.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 -0 0 0
EBITDA (mln) -0 -1 -3 -5 -10 -12 -12 -8 -6 -11 -17 -11 -20 -28 -31 -25
EBITDA(%) 0.0% 0.0% -227243.6% -1024.7% -1630.1% -2336.6% -710262.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Podatek (mln) 0 0 0 0 0 2 3 -2 1 -0 0 3 0 -1 0 0
Zysk Netto (mln) -0 -1 -3 -5 -11 -15 -16 -6 -8 -11 -17 -21 -21 -26 -30 -26
Zysk netto Δ r/r 0.0% 784.7% 216.7% 47.6% 112.3% 35.9% 7.5% -59.6% 27.5% 40.4% 51.2% 22.4% -2.3% 27.3% 14.7% -15.3%
Zysk netto (%) 0.0% 0.0% -229484.6% -1054.3% -1704.9% -2786.9% -896491.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
EPS -2.42 -32.96 -67.96 -73.43 -125.37 -109.76 -99.79 -25.93 -8.33 -2.74 -2.03 -1.87 -0.18 -0.21 -0.24 -0.2
EPS (rozwodnione) -2.42 -32.58 -67.96 -73.43 -125.37 -109.76 -99.79 -25.93 -8.33 -2.74 -2.03 -1.87 -0.18 -0.21 -0.24 -0.2
Ilośc akcji (mln) 0 0 0 0 0 0 0 0 1 4 8 11 117 127 126 126
Ważona ilośc akcji (mln) 0 0 0 0 0 0 0 0 1 4 8 11 117 127 126 126
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD